Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-Label Extension of the SANSIKA Study

scientific article published on 30 October 2018

Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-Label Extension of the SANSIKA Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLINTHERA.2018.09.012
P698PubMed publication ID30389343

P50authorAndrea LeonardiQ87781040
P2093author name stringMarc Labetoulle
Gerhard Garhöfer
Christophe Baudouin
Dahlia Ismail
Mourad Amrane
Maite Sainz de la Maza
Jean-Sébastien Garrigue
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectcyclosporineQ367700
eye diseaseQ3041498
P304page(s)1894-1906
P577publication date2018-10-30
P1433published inClinical TherapeuticsQ15716601
P1476titlePersistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study
P478volume40

Search more.